Thursday, Jan 2, 2003
South San Francisco, Calif. -- January 2, 2003 --Genentech, Inc. (NYSE: DNA) will announce its 2002 4th quarter and year-end earnings on Wednesday, January 15, 2003, after the markets close.
The announcement will be followed by a live webcast at 2:15 p.m. Pacific Time of a discussion by Genentech management of the earnings and other business results. The webcast can be accessed on Genentech's web site at http://www.gene.com and will be archived and available for replay until close of business on January 22, 2003.
An audio replay of the webcast will be available beginning at 5:15 p.m. Pacific Time on January 15, 2003 through 5:15 p.m. Pacific Time on January 22, 2003. Access numbers for this replay are: 1-800-642-1687 (U.S./Canada) and 1-706-645-9291 (international); Conference ID number is 6961386.
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. Fifteen of the currently approved biotechnology products originated from or are based on Genentech science. Genentech manufactures and commercializes ten biotechnology products directly in the United States. The company has headquarters in South San Francisco, California and is traded on the New York Stock Exchange under the symbol DNA.